BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Life Raft Group - ECPv6.17.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The Life Raft Group
X-ORIGINAL-URL:https://liferaftgroup.org
X-WR-CALDESC:Events for The Life Raft Group
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230713T120000
DTEND;TZID=America/New_York:20230713T131500
DTSTAMP:20230706T163000Z
CREATED:20230601T184055Z
LAST-MODIFIED:20230706T163000Z
UID:10000565-1689249600-1689254100@liferaftgroup.org
SUMMARY:GIST Awareness Day 2023
DESCRIPTION:July 13th\, GIST Awareness Day\, is a time where GIST experts\, patients\, caregivers can come together to educate the public about this disease and advocate towards finding a cure. The Life Raft Group invites GIST patients and caregivers to celebrate GIST Awareness Day with us on July 13th from noon to 1:15pm ET. During this virtual event\, Dr. Jason Sicklick of UC San Diego Health\, Dr. John Glod of the National Cancer Institute\, and Dr. Venkata Ramesh Bulusu of Cambridge University Hospital will discuss GIST research updates. An interactive Q&A segment will follow their presentations. \nPlease note that this webinar is not a substitute for your physician’s guidance and care.\nREGISTERAbout Our Presenters\nDr. Ramesh Bulusu\nCambridge University Hospitals \nDr. Ramesh Bulusu has trained at the Beatson Oncology Centre\, Glasgow\, Addenbrooke’s Hospital\, Cambridge and Churchill hospital\, Oxford\, before taking up his consultant position in Addenbrooke’s hospital in Cambridge in 2002.Dr Bulusu is the founder/chairman of the Cambridge Gastrointestinal Stromal Tumour (GIST) Study Group and the network lead for GISTs in Cambridge. He has served as the Track leader and member of the Sarcoma Track of the American Society of Clinical Oncology Scientific Committee from 2013-2017. \nDr Bulusu is passionate about GISTs and is currently heading a national focus group PAWS-GIST (paediatric\, adolescent\, wild type and syndromic).In 2014\, he has established a national clinic in Cambridge for PAWS-GIST to facilitate research in this rare subgroup of GISTs.\nHe is actively involved in the training and education of health care professionals in the management of GISTs and has presented and lectured extensively\, both nationally and internationally. He has co-authored the UK GIST guidelines in 2004\, 2009 and 2017. \nDr. John Glod\nNIH Center for Cancer Research\, National Cancer  \nAs a member of the Pharmacology and Experimental Therapeutics section of the NCI Pediatric Oncology Branch\, Dr. Glod’s research program focuses broadly on developing new therapies for the treatment of pediatric cancer patients with a focus on rare solid tumors. Dr. Glod has expertise in the management and treatment of patients with rare tumor predisposition syndromes including multiple endocrine neoplasia type 2B and germline succinate dehydrogenase deficiency. He is the NCI principal investigator (PI) for a natural history study of patients with MEN2B and a single institution study of guadecitabine in SDH-deficient GIST\, paraganglioma\, and renal cell cancer as well as other early phase studies in pediatric oncology. \nDr. Jason Sicklick\nMoores Cancer Center\, US San Diego Health \nis an NIH-funded investigator and Associate Professor of Surgery at the University of California San Diego Moores Cancer Center. He is a board-certified general surgeon and surgical oncologist specializing in the treatment of hepatobiliary diseases and sarcomas\, including gastrointestinal stromal tumors (GIST). In 2016\, Dr. Sicklick was named the GIST Clinician of the Year by the Life Raft GIST Support Group\, the largest GIST patient advocacy group in the world. In 2018\, Dr. Sicklick was selected as a James IV Association of Surgeons fellow. This highly prestigious international traveling fellowship is designed to promote communication and collaboration in the surgical community. In 2018 he also received the RARE Champion of Hope in Medical Care & Treatment Award from the Global Genes-Allies in Rare Disease. He obtained his medical degree from the UCLA School of Medicine\, completed his general surgery residency at The Johns Hopkins Hospital\, and completed a fellowship in surgical oncology at Memorial Sloan Kettering Cancer Center. He joined the Division of Surgical Oncology at Moores Cancer Center in 2010. \nDr. Sicklick is an active member of the National Comprehensive Cancer Network (NCCN) Sarcoma and Hepatobiliary Committees\, the Transatlantic Atlantic Retroperitoneal Sarcoma Working Group\, and the SDH GIST Consortium. Dr. Sicklick is on the Editorial Boards of Annals of Surgical Oncology\, Journal of Gastrointestinal Surgery and Journal of Surgical Research. He has published in prestigious journals such as Clinical Cancer Research\, Annals of Surgery\, JAMA Surgery\, Surgery\, and Annals of Surgical Oncology. His translational and clinical research focus on molecular mechanisms of GIST\, as well as precision medicine approaches to cancer therapy. \nThank you to our 2023 Webinar Sponsors!
URL:https://liferaftgroup.org/event/gist-awareness-day-2023-sdh-webinar/
LOCATION:NJ
CATEGORIES:Events
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
END:VCALENDAR